The GoodGene COVID-19 variant Kit (GG COVID-19 variant kit) was designed to detect clinically significant genetic mutations based on the genomic database of COVID-19. Laboratories supported by the US government have doubled the rate at which they are sequencing SARS-CoV-2 genomes over the past two months. However, we still don’t know how many COVID-19 variants there are exactly in the United states as US doesn’t have a single health system for COVID-19 surveillance.

The GoodGene COVID-19 mutation kit enables multiplexing mutation hot spots to detect most of the current COVID-19 variants of interest/concern including the “Indian mutant”. COVID variants may be more transmissible, susceptible to “vaccine escape”, or be missed by regular COVID-19 testing methods such as Real time PCR, antigen, or rapid testing.

Coronavirus variants are spreading in India — what scientists know so far

GoodGene COVID-19 mutation kit is versatile, can be run on a variety of different sequencers with a running time of ~2 hour (minus the nucleic acid extraction time) to be used in the in vitro qualitative detection of COVID-19 virus mutation from clinical specimens including nasopharyngeal, oropharyngeal, and lower respiratory specimens such as sputum.

We have 3 types of mutant kits

  1. Real Time PCR kit
    1. Single Tube , 5-Plex Real Time PCR Kit of 9 VOCs
    2. Delta variant type real-time PCR Kit, Single Tube, 4-plex (Can differentiate Delta plus from delta variant)
    3. Single Tube , 4-Plex Real Time PCR Kit of Delta/Delta plus variants
    4. Double Tube, 4-plex Real Time PCR Kit of Major VOCs
  2. Covid mutant all type SNaPshot kit (minisequencing)
  3. Covid mutant all type DNA Microarray
    : APEX DNA chip

Our technology uses special probe which has the following advantages

•High accuracy
•High sensitivity.specificity
•Sensitive allele-frequency detection
•Saving time and money
Requiring little optimization and great flexibility for the new mutations that come out as COVID-19 progresses
•(guaranteed 2 week development time for each new mutation)
High throughput level and applicability
Consistency
•can detect all microRNA without being effected by GC content
•Stable results
•can detect microRNA from hard-to-analyze samples such as FFPE or body fluids
•Allowing low costs for multiplex capability
•Easy-to-use

For collaboration contact:

    For Research Use Only. Not for use in diagnostic procedures to date.